230 related articles for article (PubMed ID: 26582870)
1. A Prospective, International Cohort Study of Invasive Mold Infections in Children.
Wattier RL; Dvorak CC; Hoffman JA; Brozovich AA; Bin-Hussain I; Groll AH; Castagnola E; Knapp KM; Zaoutis TE; Gustafsson B; Sung L; Berman D; Halasa NB; Abzug MJ; Velegraki A; Sharma TS; Fisher BT; Steinbach WJ
J Pediatric Infect Dis Soc; 2015 Dec; 4(4):313-22. PubMed ID: 26582870
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009).
Klingspor L; Saaedi B; Ljungman P; Szakos A
Mycoses; 2015 Aug; 58(8):470-7. PubMed ID: 26152371
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
4. Invasive mold infections in lung and heart-lung transplant recipients: Stanford University experience.
Vazquez R; Vazquez-Guillamet MC; Suarez J; Mooney J; Montoya JG; Dhillon GS
Transpl Infect Dis; 2015 Apr; 17(2):259-66. PubMed ID: 25648194
[TBL] [Abstract][Full Text] [Related]
5. Invasive Mold Infections in Pediatric Cancer Patients Reflect Heterogeneity in Etiology, Presentation, and Outcome: A 10-Year, Single-Institution, Retrospective Study.
Georgiadou SP; Pongas G; Fitzgerald NE; Lewis RE; Rytting M; Marom EM; Kontoyiannis DP
J Pediatric Infect Dis Soc; 2012 Jun; 1(2):125-35. PubMed ID: 26619165
[TBL] [Abstract][Full Text] [Related]
6. The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients.
Perkhofer S; Lass-Flörl C; Hell M; Russ G; Krause R; Hönigl M; Geltner C; Auberger J; Gastl G; Mitterbauer M; Willinger B; Knöbl P; Resch G; Waldner R; Makrai A; Hartmann G; Girschikofsky M; Greil R
Int J Antimicrob Agents; 2010 Dec; 36(6):531-6. PubMed ID: 20947312
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of invasive mold infections in lung transplant recipients.
Doligalski CT; Benedict K; Cleveland AA; Park B; Derado G; Pappas PG; Baddley JW; Zaas DW; Harris MT; Alexander BD
Am J Transplant; 2014 Jun; 14(6):1328-33. PubMed ID: 24726020
[TBL] [Abstract][Full Text] [Related]
8. Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey.
Blumental S; Mouy R; Mahlaoui N; Bougnoux ME; Debré M; Beauté J; Lortholary O; Blanche S; Fischer A
Clin Infect Dis; 2011 Dec; 53(12):e159-69. PubMed ID: 22080130
[TBL] [Abstract][Full Text] [Related]
9. Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation.
Glampedakis E; Roth R; Masouridi-Levrat S; Chalandon Y; Mamez AC; Giannotti F; Van Delden C; Neofytos D
J Fungi (Basel); 2021 Sep; 7(10):. PubMed ID: 34682233
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of invasive mucormycosis with isavuconazole in pediatric patients.
Barg AA; Malkiel S; Bartuv M; Greenberg G; Toren A; Keller N
Pediatr Blood Cancer; 2018 Oct; 65(10):e27281. PubMed ID: 29932282
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy for the treatment of pulmonary mold infections.
McCarthy MW; Petraitis V; Walsh TJ
Expert Rev Respir Med; 2017 Jun; 11(6):481-489. PubMed ID: 28467730
[TBL] [Abstract][Full Text] [Related]
12. Clinical Features and Survival Outcomes of Invasive Aspergillosis in Pediatric Patients at a Medical School in Thailand.
Anugulruengkitt S; Trinavarat P; Chantranuwat P; Sritippayawan S; Pancharoen C; Thanyawee P
J Med Assoc Thai; 2016 Feb; 99(2):150-8. PubMed ID: 27249894
[TBL] [Abstract][Full Text] [Related]
13. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy.
Hachem R; Gomes MZ; El Helou G; El Zakhem A; Kassis C; Ramos E; Jiang Y; Chaftari AM; Raad II
J Antimicrob Chemother; 2014 Nov; 69(11):3148-55. PubMed ID: 25006241
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies.
Hoenigl M; Zollner-Schwetz I; Sill H; Linkesch W; Lass-Flörl C; Schnedl WJ; Krause R
Mycoses; 2011 Sep; 54(5):454-9. PubMed ID: 20406398
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients.
Cesaro S; Giacchino M; Locatelli F; Spiller M; Buldini B; Castellini C; Caselli D; Giraldi E; Tucci F; Tridello G; Rossi MR; Castagnola E
BMC Infect Dis; 2007 Apr; 7():28. PubMed ID: 17442100
[TBL] [Abstract][Full Text] [Related]
16. Invasive mold infections in cancer patients: 5 years' experience with Aspergillus, Mucor, Fusarium and Acremonium infections.
Krcmery V; Kunova E; Jesenska Z; Trupl J; Spanik S; Mardiak J; Studena M; Kukuckova E
Support Care Cancer; 1996 Jan; 4(1):39-45. PubMed ID: 8771293
[TBL] [Abstract][Full Text] [Related]
17. Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies.
Hoenigl M; Raggam RB; Salzer HJ; Valentin T; Valentin A; Zollner-Schwetz I; Strohmeier AT; Seeber K; Wölfler A; Sill H; Krause R
Int J Antimicrob Agents; 2012 Jun; 39(6):510-3. PubMed ID: 22481057
[TBL] [Abstract][Full Text] [Related]
18. Antifungal therapy in children with invasive fungal infections: a systematic review.
Blyth CC; Palasanthiran P; O'Brien TA
Pediatrics; 2007 Apr; 119(4):772-84. PubMed ID: 17403849
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological features of invasive mold infections among solid organ transplant recipients: PATH Alliance® registry analysis.
Husain S; Silveira FP; Azie N; Franks B; Horn D
Med Mycol; 2017 Apr; 55(3):269-277. PubMed ID: 27703022
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.
Montesinos P; Rodríguez-Veiga R; Boluda B; Martínez-Cuadrón D; Cano I; Lancharro A; Sanz J; Arilla MJ; López-Chuliá F; Navarro I; Lorenzo I; Salavert M; Pemán J; Calvillo P; Martínez J; Carpio N; Jarque I; Sanz GF; Sanz MA
Bone Marrow Transplant; 2015 Nov; 50(11):1465-72. PubMed ID: 26281032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
